Ironwood Pharmaceuticals (IRWD) Analyst & Key Data

Analyst Consensus

Hold4 analysts

Hold

Updated Sep 12, 2026

Total Analysts4

Buy

11

Hold

16

Sell

3

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.08

Median Target+11.52%

$4.55

Potential upside vs current price

DCF Value+47.52%

$6.02

Potential upside vs current price

Current Stock Price

$4.08

Median Target+11.52%

$4.55

Potential upside vs current price

DCF Value+47.52%

$6.02

Potential upside vs current price

Analyst Consensus

Hold4 analysts

Hold

Updated Sep 12, 2026

Total Analysts4

Buy

11

Hold

16

Sell

3

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.08

Median Target+11.52%

$4.55

Potential upside vs current price

DCF Value+47.52%

$6.02

Potential upside vs current price

Current Stock Price

$4.08

Median Target+11.52%

$4.55

Potential upside vs current price

DCF Value+47.52%

$6.02

Potential upside vs current price

Ironwood Pharmaceuticals, Inc.